Compound information
- Natural Products
- NACP1386
- Molecular Formula
- C28H40N2O4S2
- Molecular Weight
- 532.24294976 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[1-[[[2-(benzyloxycarbonylamino)-4-methyl-pentyl]disulfanyl]methyl]-3-methyl-butyl]carbamate
- InChI
- InChI=1S/C28H40N2O4S2/c1-21(2)15-25(29-27(31)33-17-23-11-7-5-8-12-23)19-35-36-20-26(16-22(3)4)30-28(32)34-18-24-13-9-6-10-14-24/h5-14,21-22,25-26H,15-20H2,1-4H3,(H,29,31)(H,30,32)
- InChI Key
- AEWOICLODRFYKF-UHFFFAOYSA-N
- SMILES
- O=C(OCC=1C=CC=CC1)NC(CSSCC(NC(=O)OCC=2C=CC=CC2)CC(C)C)CC(C)C
- CAS
- 77412-29-4
- SuperClass
- Benzenoids
- Class
- Benzene and substituted derivatives
- SubClass
- Benzyloxycarbonyls
- Source
- CNP0070915
Warheads
- Carbamate
-
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 36 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 15 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 76.66 Å2 | LogP | 6.507 |
LogS | -5.384 | LogD | 5.231 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.998 | Pgp substrate | 0.178 |
HIA | 0.965 | F20 % | 0.991 |
F30 % | 0.738 | Caco-2 | -4.865 |
MDCK | -4.601 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.205 | PPB | 98.063 |
VD | 0.767 | Fu | 2.125 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.446 | CYP1A2 substrate | 0.65 |
CYP2A6 substrate | 0.445 | CYP2B6 substrate | 0.676 |
CYP2C19 inhibitor | 0.978 | CYP2C19 substrate | 0.753 |
CYP2C8 substrate | 0.73 | CYP2C9 inhibitor | 0.95 |
CYP2C9 substrate | 0.132 | CYP2D6 inhibitor | 0.529 |
CYP2D6 substrate | 0.406 | CYP2E1 substrate | 0.199 |
CYP3A4 inhibitor | 0.991 | CYP3A4 substrate | 0.991 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.733 | CL | 5.005 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.013 | Hepatotoxicity | 0.999 |
Mutagenicity | 0.206 | Rat Oral Acute Toxicity | 0.041 |
FDAMDD | 0.461 | Skin Sensitization | 0.452 |
Carcinogenicity | 0.011 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.125 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.336 | IGC50 | 5.227 |
LC50FM | 5.909 | LC50DM | 6.328 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.242 | NR-AR-LBD | 0.147 |
NR-AhR | 0.006 | NR-Aromatase | 0.044 |
NR-ER | 0.326 | NR-ER-LBD | 0.502 |
NR-PPAR-gamma | 0.21 | SR-ARE | 0.291 |
SR-ATAD5 | 0.528 | SR-HSE | 0.481 |
SR-MMP | 0.59 | SR-p53 | 0.235 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.